(D-Lys16)-ACTH (1-24) (human, bovine, rat) trifluoroacetate salt incorporates a D-lysine substitution within the ACTH(1-24) framework. The modification alters conformational preferences and receptor-contact characteristics. Its conserved sequence across species enables comparative signaling research. Researchers use it in structure-activity studies, peptide analog evaluation, and receptor-binding assays.
CAT No: A03047
CAS No:494750-52-6
Synonyms/Alias:(D-Lys¹⁶)-Tetracosactide, (D-Lys16)-ACTH (1-24) human, bovine, mouse, ovine, porcine, rabbit, rat
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.